Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based

Ann Neurol. 2014 Jan;75(1):163-4. doi: 10.1002/ana.24047. Epub 2014 Jan 2.

Authors

Iris E Overwater¹, André B Rietman, Ype Elgersma, Marie-Claire Y de Wit

Affiliation

¹ Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands; Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

PMID: 24243580
DOI: 10.1002/ana.24047

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticonvulsants / therapeutic use*
Brain / drug effects*
Epilepsy / drug therapy*
Female
Humans
Male
Quality of Life*
Sirolimus / analogs & derivatives*
Tuberous Sclerosis / drug therapy*

Substances

Anticonvulsants
Sirolimus